ATLASHaemonetics (HAE) earnings date: Nov 5, 2026
Haemonetics (HAE) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, before the open. Analysts expect EPS of $1.30.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on HAE
| Last price | $120.16 (+0.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.5% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Haemonetics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Haemonetics reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Haemonetics. You can switch it off at any time.
Alert me before HAE reportsFree to start. Creating an account takes under a minute.
Notify me when Haemonetics reports
Track HAE free Add Haemonetics to a free ATLAS watchlist and see its next report date in one place.
HAE earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $1.30 |
| Last report | Aug 6, 2026 · Beat |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | +4.0% |
| Average move around a report | ±3.7% (last 4) |
| Sector | Healthcare · Medical Devices |
Haemonetics earnings history: last 4 reports
Haemonetics last reported on Aug 6, 2026: EPS of $1.14 against an estimate of $1.08 (+5.6% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | $1.08 | $1.14 | +5.6% | Beat | +5.1% |
| Jun 15, 2026 | -$0.47 | -$0.43 | +8.5% | Beat | -4.8% |
| May 7, 2026 | $1.27 | $1.29 | +1.6% | In line | +4.7% |
| Feb 3, 2026 | $3.32 | $3.33 | +0.3% | In line | +0.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for HAE
See the fair value, the probability range and the earnings history of Haemonetics on its ATLAS page.
Haemonetics (HAE) stock analysisPlans from €3.99 a month.
Haemonetics earnings: frequently asked questions
When does Haemonetics (HAE) report earnings?
Haemonetics is scheduled to report on Thursday, November 5, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for HAE?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $1.30 per share (USD). Estimates can change before the report.
How often does HAE beat earnings estimates?
Of its last 4 reports with a recorded result, Haemonetics beat the EPS estimate 2 times; the average surprise was +4.0%. Past results do not predict the next one.
How much does HAE move around earnings?
Over its last 4 reports the stock moved an average of 3.7% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did Haemonetics beat earnings estimates last quarter?
Haemonetics last reported on Aug 6, 2026: EPS of $1.14 against an estimate of $1.08 (+5.6% surprise), a beat.
How much does HAE usually move in a day?
On a normal trading day the ATLAS model puts HAE’s one-day range at about ±2.5%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer